![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy and Safety of Raltegravir Among Latin American Patients in STARTMRK
|
|
|
Reported by Jules Levin
ICAAC 2013 Sept 10-13 Denver, CO
Mauro Schechter1, Juan Sierra-Madero2, Carlos Beltran3, Jose V. Madruga4, Kim Strohmaier5, Anthony Rodgers5, Hedy Teppler5, Randi Leavitt5, Peter Sklar5
1Univ. Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 2Inst. Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico; 3Hosp. Barros Luco Trudeau, Santiago, Chile; 4Centro de Referencia e Treinamento DST/AIDS, Sao Paulo, Brazil; 5Merck, Whitehouse Station, NJ
![ICAAC1.gif](../images/091613/091613-2/ICAAC1.gif)
![ICAAC2.gif](../images/091613/091613-2/ICAAC2.gif)
![ICAAC3.gif](../images/091613/091613-2/ICAAC3.gif)
![ICAAC4.gif](../images/091613/091613-2/ICAAC4.gif)
![ICAAC5.gif](../images/091613/091613-2/ICAAC5.gif)
![ICAAC6.gif](../images/091613/091613-2/ICAAC6.gif)
![ICAAC7.gif](../images/091613/091613-2/ICAAC7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|